1047 (1047) Fair Value & Analysis

Basic Materials · Market cap HK$118M

1 1047 1047 · HK

PriceHK$0.3200

Fair ValueHK$0.5400

Upside+68.8%

Quality55/100

Evidence: High Range HK$0.3600 – HK$0.5400

Fair value as of: Jul 2, 2026

From 22 valuation models · updated today

Share price −1.5% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2550 – HK$0.4300 · fair‑value band HK$0.3600 – HK$0.5400 · the HK$0.3200 price screens below the HK$0.5400 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1047 (1047) currently trades at HK$0.3200, while our model-based Fair Value estimate is HK$0.5400 — implying the stock looks roughly 68.8% undervalued today. We read business quality at 55/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 1047 generated revenue of HK$1.3B at a net margin of 0.7%. Revenue declined 2.4% year over year. It earns a return on equity of 1.8%. Net debt stands at HK$216M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.3B

Revenue growth (YoY) -2.4%

Net margin 0.7%

Return on equity 1.8%

Free cash flow HK$72.0M FY2025

P/E ratio 10.7

More key figures

Operating margin 2.6%

EPS (TTM) HK$0.0400

EPS growth (YoY) +1,824%

Net debt HK$216M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1047 reported revenue of HK$1.3B in FY2025 versus HK$2.0B in FY2021, a compound −9.1%/yr. Reported net income was HK$339K in FY2025, compounding −75.2%/yr from FY2021.

Revenue −9.1%/yr

FY21 HK$2.0B

FY22 HK$1.7B

FY23 HK$1.2B

FY24 HK$1.3B

FY25 HK$1.3B

Net income −75.2%/yr

FY21 HK$89.9M

FY22 HK$56.6M

FY23 −HK$52.0M

FY24 −HK$18.0M

FY25 HK$339K

Is 1047 fairly valued? → Check now

Similar stocks

6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Linde plc LIN	$516.71	$221.55	-57%
L'Air Liquide S.A AIQUY	$37.81	$15.56	-59%
Air Products and Chemicals, Inc A1PD34	R$360.05	R$174.71	-51%
Intercontinental Exchange, Inc I1CE34	R$334.47	R$86.67	-74%
Wanhua Chemical Group 600309	¥67.90	¥46.52	-31%
Asian Paints Limited ASIANPAINT	₹2,687	₹655.71	-76%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1047 (1047) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.5400 versus a price of HK$0.3200 — about +69% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1047?

Our model-based fair value for 1047 is HK$0.5400 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.3200.

What is the quality score of 1047?

1047 has a Quality Score of 55/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1047 (1047)?

1047 reported trailing-twelve-month revenue of about HK$1.3B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1047?

The net profit margin of 1047 is about 0.7%, meaning it keeps roughly 0.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.